Profile
| Metric | Value |
|---|---|
| Full Name | Globus Medical, Inc. |
| Ticker | NYSE: GMED |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Medical Devices |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | globusmedical.com |
| Employees | 5,300 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $94.62 | |
| Price, 1D Change | +4.51% | |
| Market Cap | $13B | |
| - | ||
| PE Ratio | 30.58 | |
| Beta | 1.04 | |
| Revenue | $3B | |
| Revenue, 1Y Change | +60.62% | |
| EPS | $0.75 | |
| EPS, 1Y Change | -30.31% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | $0.75 | |
| EPS Estimate | $3.79 | |
| EPS Est. Change | +408.01% | |
| Revenue | $2.52B | |
| Revenue Estimate | $2.89B | |
| Revenue Est. Change | +14.71% | |
| Current Price | $94.62 | |
| Price Target | - | $100.00 |
| Price Tgt. Change | - | +5.69% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $2.31 | $1.07 | -53.60% | |
| $2.99 | $0.75 | -75.00% | |
| $3.79 | N/A | +408.01% | |
| $4.12 | N/A | +451.15% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $1.56B | $1.57B | +0.58% | |
| $2.51B | $2.52B | +0.44% | |
| $2.89B | N/A | +14.71% | |
| $3.12B | N/A | +23.67% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | +9.32% | |
| Price, 3Y | +31.02% | |
| Market Cap, 1Y | +6.48% | |
| Market Cap, 3Y | +75.01% | |
| Revenue, 1Y | +60.62% | |
| Revenue, 3Y | +162.95% | |
| EPS, 1Y | -30.31% | |
| EPS, 3Y | -48.12% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $94.62 | |
| SMA 200 | $66.88 | |
| SMA 200 vs Price | -29.32% | |
| SMA 50 | $83.47 | |
| SMA 50 vs Price | -11.78% | |
| Beta | 1.04 | |
| ATR | $2.85 | |
| 14-Day RSI | 67.81 | |
| 10-Day Volatility | 36.78% | |
| 1-Year Volatility | 53.82% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| Dividends Paid | $0.00 | |
| Payout Ratio | 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $2.52B | |
| EPS | $0.75 | |
| Gross Profit | $1.48B | |
| Gross Margin | 58.90% | |
| Operating Profit | $219.70M | |
| Operating Margin | 8.72% | |
| Net Income | $102.98M | |
| Net Margin | 4.09% | |
| EBITDA | $473.73M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 0.13 | |
| Current Ratio | 2.54 | |
| Quick Ratio | 1.77 | |
| - | ||
| F-Score | 8 | |
| Altman Z-Score | 8.30 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | 30.58 | |
| PS Ratio | 4.57 | |
| PB Ratio | 2.88 | |
| EV/EBITDA | 17.10 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $4.18B | |
| Cash & Equivalents | $890.06M | |
| Total Assets | $5.25B | |
| Current Assets | $2.18B | |
| Total Liabilities | $1.07B | |
| Current Liabilities | $855.91M | |
| Total Debt | $537.72M | |
| Short Term Debt | $453.83M | |
| Accounts Payable | $75.12M |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $2.30B | |
| Operating Expenses | $1.26B | |
| Cost Of Goods Sold | $1.04B | |
| SG&A | $981.05M | |
| D&A | $254.02M | |
| Interest Expense | $0.00 | |
| Income Tax | $17.74M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | $520.64M | |
| CFI | -$176.05M | |
| CFF | -$27.70M | |
| Capex | $115.43M | |
| Free Cash Flow | $405.21M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| RBC Capital | → | |
| Freedom Capital Markets | ||
| Canaccord Genuity | → | |
| Morgan Stanley | → | |
| Truist Securities | → | |
| Barclays | → | |
| Wells Fargo | → | |
| Truist Securities | → | |
| RBC Capital | → | |
| B of A Securities | → |
Analyst sentiment
Institutional ownership
Screeners with GMED
Data Sources & References
- GMED Official Website www.globusmedical.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1237831/000123783125000031/0001237831-25-000031-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1237831/000156276225000026/0001562762-25-000026-index.htm
- GMED Profile on Yahoo Finance finance.yahoo.com/quote/GMED
- GMED Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/gmed
FAQ
What is the ticker symbol for Globus Medical, Inc.?
The ticker symbol for Globus Medical, Inc. is NYSE:GMED
Does Globus Medical, Inc. pay dividends?
No, Globus Medical, Inc. does not pay dividends
What sector is Globus Medical, Inc. in?
Globus Medical, Inc. is in the Healthcare sector
What industry is Globus Medical, Inc. in?
Globus Medical, Inc. is in the Medical Devices industry
What country is Globus Medical, Inc. based in?
Globus Medical, Inc. is headquartered in United States
When did Globus Medical, Inc. go public?
Globus Medical, Inc. initial public offering (IPO) was on August 3, 2012
Is Globus Medical, Inc. in the S&P 500?
No, Globus Medical, Inc. is not included in the S&P 500 index
Is Globus Medical, Inc. in the NASDAQ 100?
No, Globus Medical, Inc. is not included in the NASDAQ 100 index
Is Globus Medical, Inc. in the Dow Jones?
No, Globus Medical, Inc. is not included in the Dow Jones index
When was Globus Medical, Inc. last earnings report?
Globus Medical, Inc.'s most recent earnings report was on November 6, 2025
When does Globus Medical, Inc. report earnings?
The next expected earnings date for Globus Medical, Inc. is February 24, 2026